Cite
HARVARD Citation
Lambru, G. et al. (2022). 056 Efficacy of fremanezumab in chronic migraine patients with inadequate response to ≥3 preventive medication classes. Journal of neurology, neurosurgery and psychiatry. 93 (6), p. A118. [Online].